Layer Raises $6.6M Led by Emergence Capital to Bring Embedded Accounting to the SMB Software Stack

Layer Raises $6.6M Led by Emergence Capital to Bring Embedded Accounting to the SMB Software Stack New funding will fuel expansion into additional SMB verticals and enhancement of AI-powered bookkeeping solutions GlobeNewswire July 09, 2025 SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) — Layer, the leading embedded accounting platform for small and medium-size business (SMB) […]

KULR Reaches 750 PH/s in Bitcoin Mining Operations with Latest Deployment, Aims for 1.25 EH/s by Late Summer

KULR Reaches 750 PH/s in Bitcoin Mining Operations with Latest Deployment, Aims for 1.25 EH/s by Late Summer GlobeNewswire July 09, 2025 HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a Bitcoin First Company and global leader in sustainable energy management, today announced the successful

Lightbridge Announces Participation in Upcoming Industry and Investor Events

Lightbridge Announces Participation in Upcoming Industry and Investor Events GlobeNewswire July 09, 2025 RESTON, Va., July 09, 2025 (GLOBE NEWSWIRE) — Lightbridge Corporation (Nasdaq: LTBR), a leader in advanced nuclear fuel technology, today announced that management will participate in the following industry conferences and events: H.C. Wainwright Powering the Future ConferenceSeth Grae, President and Chief

Sprott Silver Miners & Physical Silver ETF Reaches $100 Million in Assets

Sprott Silver Miners & Physical Silver ETF Reaches $100 Million in Assets GlobeNewswire July 09, 2025 Only1 U.S.-Listed ETF Providing Pure-Play2 Exposure to Silver Miners and Physical Silver Rapidly Gains Assets TORONTO, July 09, 2025 (GLOBE NEWSWIRE) — Sprott Asset Management USA, Inc. today announced that the Sprott Silver Miners & Physical Silver ETF (Nasdaq:

Immuneering Granted U.S. Composition of Matter Patent for Highly Differentiated Cancer Drug Candidate Atebimetinib

Immuneering Granted U.S. Composition of Matter Patent for Highly Differentiated Cancer Drug Candidate Atebimetinib GlobeNewswire July 09, 2025 – Newly issued U.S. composition of matter patent expected to provide exclusivity into 2042, with subsequent opportunity for patent term extension – – First U.S. patent granted on a deep cyclic inhibitor: a once-daily pill that aims

OrangeKloud signs Contract for the Supply and Implementation of Cloud Workspace Terminals

OrangeKloud signs Contract for the Supply and Implementation of Cloud Workspace Terminals GlobeNewswire July 09, 2025 SINGAPORE, July 09, 2025 (GLOBE NEWSWIRE) — OrangeKloud Technology Inc. (Nasdaq: ORKT) (“OrangeKloud” or “the Company“), a Singapore-based technology company offering the eMOBIQ(R) No-Code platform for development of mobile applications, is pleased to announce the signing of a contract

DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors

DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors Appointment highlights DIMERx's next phase of growth as it advances non-addictive pain therapeutics with support from the NIH HEAL Initiative GlobeNewswire July 09, 2025 SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) — DIMERx, Inc., a late-stage clinical biopharmaceutical company developing covalently bonded dimer therapeutics,

Magnite to Announce Second Quarter 2025 Financial Results on August 6, 2025

Magnite to Announce Second Quarter 2025 Financial Results on August 6, 2025 GlobeNewswire July 09, 2025 NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, will announce its financial results for the second quarter ended June 30, 2025 after the market close on Wednesday, August 6, 2025.

CoRegen, Inc. Closes More Than $93 Million Financing

CoRegen, Inc. Closes More Than $93 Million Financing Proceeds to support key development milestones, including CMC advancement, initiation of a Phase I clinical trial in the first half of 2026, and strategic expansion of the leadership team GlobeNewswire July 09, 2025 HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) — CoRegen, Inc., a biopharmaceutical company pursuing novel

Cingulate Appoints Nilay Patel as Chief Legal Officer to Support Growth ahead of New Drug Application

Cingulate Appoints Nilay Patel as Chief Legal Officer to Support Growth ahead of New Drug Application Pharma Vet brings 20+ years of Legal, Compliance, and Commercialization Expertise as Company prepares ADHD Drug Filing GlobeNewswire July 09, 2025 KANSAS CITY, Kan., July 09, 2025 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its

Scroll to Top